<page><title>MED13L syndrome</title><url>https://medlineplus.gov/genetics/condition/med13l-syndrome</url><content>MED13L syndrome
To use the sharing features on this page, please enable JavaScript.
Description
MED13L
syndrome is a developmental disorder characterized by developmental delay, intellectual disability, and minor differences in facial features. Additionally, some people with this condition have recurrent seizures (epilepsy) or heart abnormalities that are present from birth (congenital heart defects).
Intellectual disability and developmental delay are usually moderate to severe in people with
MED13L
syndrome. Weak muscle tone (hypotonia) and delayed development of motor skills, such as sitting, standing, and walking, are early symptoms of the condition. After learning to walk, some affected individuals continue to have difficulty with coordination and balance (ataxia). Speech is also delayed, and most people with this condition develop only a few words or never learn to talk. People with
MED13L
syndrome may exhibit characteristics typical of
autism spectrum disorder
, including repetitive actions and difficulty with social interactions.
Most people with
MED13L
syndrome have unusual facial features that consist of a
depressed nasal bridge
,
a bulbous nasal tip
,
straight eyebrows
, outside corners of the eyes that point upward (
upslanting palpebral fissures
),
full cheeks
, and an open mouth. Other facial features that sometimes occur are a pronounced double curve of the upper lip (
Cupid's bow
), and a deep space between the nose and upper lip (
philtrum
).
Different congenital heart defects can occur in
MED13L
syndrome. Affected individuals may have transposition of the great arteries, which is abnormal positioning of the large blood vessel that distributes blood from the heart to the rest of the body (aorta) and the artery that carries blood from the heart to the lungs (
the pulmonary artery
). Other congenital heart defects in
MED13L
syndrome include a hole between the two lower chambers of the heart (
ventricular septal defect
), a hole between the two upper chambers of the heart (patent foramen ovale), or a particular combination of heart defects known as
tetralogy of Fallot
.
Frequency
MED13L
syndrome is a rare disorder that occurs in an estimated 1.6 per 100,000 newborns. More than 65 affected individuals have been reported in the scientific literature.
Causes
As its name suggests,
MED13L
syndrome is caused by mutations in a gene known as
MED13L
. This gene provides instructions for making a protein that helps regulate gene activity; it is thought to play an essential role in development both before and after birth. The
MED13L
gene mutations that cause this condition alter the function of the MED13L protein or reduce the amount of protein present, impairing normal control of gene activity. It is unclear how these changes lead to the particular developmental and physical features of
MED13L
syndrome.
Learn more about the gene associated with MED13L syndrome
MED13L
Inheritance
MED13L
syndrome is inherited in an autosomal dominant pattern, which means one copy of the altered
MED13L
gene in each cell is sufficient to cause the disorder. Most cases of this condition result from new (de novo) mutations in the gene that occur during the formation of reproductive cells (eggs or sperm) or in early embryonic development. These cases occur in people with no history of the disorder in their family. Very rarely, the condition is inherited from a parent with mosaicism. In these instances, the parent has a
MED13L
gene mutation in a small number of cells, including reproductive cells (eggs or sperm), and does not show any signs or symptoms of
MED13L
syndrome.
Other Names for This Condition
Asadollahi-Rauch syndrome
ASRAS
Cardiac anomalies-developmental delay-facial dysmorphism syndrome
Developmental delay-facial dysmorphism syndrome due to MED13L deficiency
Intellectual disability and distinctive facial features with or without cardiac defects
MED13L haploinsufficiency syndrome
MED13L-related intellectual disability
MRFACD
Additional Information &amp; Resources
Genetic Testing Information
Genetic Testing Registry: Cardiac anomalies - developmental delay - facial dysmorphism syndrome
Genetic and Rare Diseases Information Center
MED13L haploinsufficiency syndrome
Patient Support and Advocacy Resources
National Organization for Rare Disorders (NORD)
Catalog of Genes and Diseases from OMIM
IMPAIRED INTELLECTUAL DEVELOPMENT AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD
Scientific Articles on PubMed
PubMed
References
Asadollahi R, Oneda B, Sheth F, Azzarello-Burri S, Baldinger R, Joset P, Latal
B, Knirsch W, Desai S, Baumer A, Houge G, Andrieux J, Rauch A. Dosage changes of
MED13L further delineate its role in congenital heart defects and intellectual
disability. Eur J Hum Genet. 2013 Oct;21(10):1100-4. doi: 10.1038/ejhg.2013.17.
Epub 2013 Feb 13.
Citation on PubMed
or
Free article on PubMed Central
Asadollahi R, Zweier M, Gogoll L, Schiffmann R, Sticht H, Steindl K, Rauch A.
Genotype-phenotype evaluation of MED13L defects in the light of a novel
truncating and a recurrent missense mutation. Eur J Med Genet. 2017
Sep;60(9):451-464. doi: 10.1016/j.ejmg.2017.06.004. Epub 2017 Jun 21.
Citation on PubMed
Cafiero C, Marangi G, Orteschi D, Ali M, Asaro A, Ponzi E, Moncada A,
Ricciardi S, Murdolo M, Mancano G, Contaldo I, Leuzzi V, Battaglia D, Mercuri E,
Slavotinek AM, Zollino M. Novel de novo heterozygous loss-of-function variants in
MED13L and further delineation of the MED13L haploinsufficiency syndrome. Eur J
Hum Genet. 2015 Nov;23(11):1499-504. doi: 10.1038/ejhg.2015.19. Epub 2015 Feb 25.
Citation on PubMed
or
Free article on PubMed Central
Smol T, Petit F, Piton A, Keren B, Sanlaville D, Afenjar A, Baker S, Bedoukian
EC, Bhoj EJ, Bonneau D, Boudry-Labis E, Bouquillon S, Boute-Benejean O, Caumes R,
Chatron N, Colson C, Coubes C, Coutton C, Devillard F, Dieux-Coeslier A,
Doco-Fenzy M, Ewans LJ, Faivre L, Fassi E, Field M, Fournier C, Francannet C,
Genevieve D, Giurgea I, Goldenberg A, Green AK, Guerrot AM, Heron D, Isidor B,
Keena BA, Krock BL, Kuentz P, Lapi E, Le Meur N, Lesca G, Li D, Marey I, Mignot
C, Nava C, Nesbitt A, Nicolas G, Roche-Lestienne C, Roscioli T, Satre V, Santani
A, Stefanova M, Steinwall Larsen S, Saugier-Veber P, Picker-Minh S, Thuillier C,
Verloes A, Vieville G, Wenzel M, Willems M, Whalen S, Zarate YA, Ziegler A,
Manouvrier-Hanu S, Kalscheuer VM, Gerard B, Ghoumid J. MED13L-related
intellectual disability: involvement of missense variants and delineation of the
phenotype. Neurogenetics. 2018 May;19(2):93-103. doi: 10.1007/s10048-018-0541-0.
Epub 2018 Mar 6.
Citation on PubMed
van Haelst MM, Monroe GR, Duran K, van Binsbergen E, Breur JM, Giltay JC, van
Haaften G. Further confirmation of the MED13L haploinsufficiency syndrome. Eur J
Hum Genet. 2015 Jan;23(1):135-8. doi: 10.1038/ejhg.2014.69. Epub 2014 Apr 30.
Citation on PubMed
or
Free article on PubMed Central
Yamamoto T, Shimojima K, Ondo Y, Shimakawa S, Okamoto N. MED13L
haploinsufficiency syndrome: A de novo frameshift and recurrent intragenic
deletions due to parental mosaicism. Am J Med Genet A. 2017 May;173(5):1264-1269.
doi: 10.1002/ajmg.a.38168. Epub 2017 Mar 29.
Citation on PubMed
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Official websites use .gov
A
.gov
website belongs to an official government
              organization in the United States.
Secure .gov websites use HTTPS
A
lock
(
Lock
Locked padlock icon
) or
https://
means youâ€™ve safely connected to
              the .gov website. Share sensitive information only on official,
              secure websites.</content></page>